National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Ogilvie syndrome is not the name you expected.
Ogilvie syndrome is a rare, acquired disorder characterized by abnormalities affecting the involuntary, rhythmic muscular contractions (peristalsis) within the colon. Peristalsis propels food and other material through the digestive system through the coordination of muscles, nerves and hormones. The colon is often significantly widened (dilated). Symptoms are similar to other forms of intestinal pseudo-obstruction and can include nausea, vomiting, abdominal bloating or swelling and constipation. The symptoms of Ogilvie syndrome mimic those of mechanical obstruction of the colon, but no such physical obstruction is present. Mechanical obstruction refers to something (e.g., tumor, scar tissue, etc.) physically blocking the passage of food and other material through the GI tract. Ogilvie syndrome is usually associated with an underlying disorder, trauma or surgery. Ogilvie syndrome can be managed with conservative treatment, but if unrecognized and untreated can lead to serious, potentially life-threatening complications.
Ogilvie syndrome was first described in the medical literature in 1948 by a British surgeon named Sir William Ogilvie. The disorder is also known as acute colonic pseudo-obstruction (ACPO). It is not the same as chronic intestinal pseudo-obstruction, a similar, but distinct disorder.
Association of Gastrointestinal Motility Disorders, Inc. (AGMD)
- 12 Roberts Drive
- Bedford, MA 1730
- Tel: (781)275-1300
- Fax: (781)275-1304
- Email: firstname.lastname@example.org.
- Website: http://www.agmd-gimotility.org
Bowel Group for Kids Inc.
- PO Box 40
- Oakdale, NSW, 2570
- Tel: 02 4659 6067
- Fax: 61 2 4659 6381
- Email: email@example.com
- Website: http://www.bgk.org.au
- 3 St. Andrews Place
- London, NW1 4LB
- United Kingdom
- Tel: 2074860341
- Fax: 2072242012
- Email: firstname.lastname@example.org
- Website: http://www.corecharity.org.uk
Digestive Disease National Coalition
- 507 Capitol Court, NE
- Suite 200
- Washington, DC 20002
- Tel: (202)544-7497
- Fax: (202)546-7105
- Email: email@example.com
- Website: http://www.ddnc.org
Genetic and Rare Diseases (GARD) Information Center
- PO Box 8126
- Gaithersburg, MD 20898-8126
- Tel: (301)251-4925
- Fax: (301)251-4911
- Tel: (888)205-2311
- Website: http://rarediseases.info.nih.gov/GARD/
International Foundation for Functional Gastrointestinal Disorders
- 700 W. Virginia St., 201
- Milwaukee, WI 53217
- Tel: (414)964-1799
- Fax: (414)964-7176
- Tel: (888)964-2001
- Email: firstname.lastname@example.org
- Website: http://www.iffgd.org
NIH/National Institute of Diabetes, Digestive & Kidney Diseases
- Office of Communications & Public Liaison
- Bldg 31, Rm 9A06
- Bethesda, MD 20892-2560
- Tel: (301)496-3583
- Email: NDDIC@info.niddk.nih.gov
- Website: http://www2.niddk.nih.gov/
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders (NORD). For a full-text version of this report, go to www.rarediseases.org and click on Rare Disease Database under "Rare Disease Information".
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report.
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
Last Updated: 3/13/2012
Copyright 2012 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.